Clinical Trial Update: A Open-label, Randomized, Crossover Study to Assess PK of Pregabalin [Phase 1]

View source ↗

Summary

This open-label, randomized, crossover Phase 1 study assesses the pharmacokinetics of pregabalin in individuals with peripheral neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathy

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Yuhan Corporation | Conditions: Peripheral Nueropathy Pain | Phase 1 | Status: COMPLETED